The FDA is planning to tighten its regulations for vaccines, according to an internal email sent by Vinay Prasad, M.D., who heads up the agency’s Center for Biologics Evaluation and Research (CBER).
Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Lawrence spoke with more than 15 current and former FDA insiders and reviewed internal emails and memos to report this story. Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration.
A top official at the Food and Drug Administration steps down after the agency changes course on a treatment for Duchenne muscular dystrophy. What does this say about the Trump Administration's ...
Durga Puja 2025: Durga Puja is not just a religious festival but a vibrant cultural celebration that brings communities together. Rooted in Hindu mythology, it marks the victory of good over evil and ...
Vinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last month, is set to return to his post, according to the Department of Health and Human Services (HHS). ...
Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. “At the FDA’s request, Dr. Vinay Prasad is resuming leadership of the Center for ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Vinay Prasad is ...
Vinay Prasad is my former student and friend. His departure from FDA is a loss for American medicine
A version of this piece first appeared in Sensible Medicine. Vinay Prasad, Marty Makary, and Adam Cifu, among others, were founding members of Sensible Medicine. Prasad and Cifu also co-authored a ...
Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration (FDA) and a critic of the agency’s COVID-19 policies, has departed after being on the job for ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. Vinay Prasad had a problem.
Matthew Herper covers medical innovation — both its promise and its perils. Vinay Prasad’s three-month tenure as one of the top officials at the Food and Drug Administration was bad for medicine. But ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback